Medical device labeling and advertising: an overview.

Area of Science:

• Medical Device Regulation
• Health Law
• Regulatory Affairs

Background:

• The Food and Drug Administration (FDA) holds regulatory authority over medical device labeling via the Federal Food, Drug, and Cosmetic Act (FDCA).
• Medical device labeling and advertising regulations are complex and evolving, posing ongoing challenges for the FDA.
• Understanding the nuances of FDA regulation is crucial for manufacturers and marketers of medical devices.

Purpose of the Study:

• To provide foundational knowledge of current laws and FDA's regulatory framework for medical devices.
• To summarize existing laws and regulations pertinent to medical device governance.
• To clarify the definition and significance of "intended use" in medical device regulation.

Main Methods:

• Literature review of the Federal Food, Drug, and Cosmetic Act (FDCA) and related regulations.
• Analysis of FDA guidance documents and policy statements on medical device labeling and promotion.
• Discussion of key regulatory concepts, including "intended use" and specific promotional activities.

Main Results:

• The FDA's regulatory purview encompasses medical device labeling and advertising, guided by the FDCA.
• Key areas of FDA focus include the promotion of uncleared/unapproved devices and uses, internet promotion, press releases, and comparative claims.
• The definition and accurate determination of "intended use" are critical for compliance.

Conclusions:

• Navigating FDA regulations for medical device labeling and promotion requires a thorough understanding of the FDCA and related policies.
• The FDA actively monitors and addresses emerging issues in medical device promotion, especially concerning digital platforms and claims.
• Accurate labeling and adherence to "intended use" are paramount for regulatory compliance and patient safety.